Lucira Health Inc - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
LHDX Nasdaq 2835 https://www.lucirahealth.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Lucira Health Inc

The Zacks Analyst Blog Highlights AppHarvest, Lucira Health, Lucid Group, Life Time Group and Ameriprise Financial - Feb 2nd, 2023 2:30 pm
5 Big Winners as Wall Street Wraps Up Strong January Gains - Feb 1st, 2023 1:16 pm
SESAME PARTNERS WITH LUCIRA HEALTH AS OFFICIAL TELEHEALTH PROVIDER OF LAB-QUALITY TEST-TO-TREAT PROGRAM - Jan 5th, 2023 2:00 pm
As EU works to coordinate response to China’s COVID wave, Beijing and airlines are unhappy - Jan 4th, 2023 3:40 pm
Lucira Health Launches Lucira Connect, a Free Test-to-Treat Telehealth Service for Covid-19 or Flu in Canada - Jan 4th, 2023 12:00 pm
Lucira Health Submits EUA for Over-The-Counter (OTC) Use of its COVID-19 & Flu Test - Jan 3rd, 2023 12:00 pm
Skillz, Grove Collaborative and Lucira Health receive delisting notices - Dec 21st, 2022 7:44 pm
Lucira and Loch Lomond Villa Announce Clinical Study to Tackle Tripledemic With First and Only Combination COVID-19 and Flu OTC Molecular Self-Test - Dec 6th, 2022 12:03 pm
Lucira Health Announces FDA Authorization of Combination COVID-19 & Flu Test at Point-of-Care - Nov 22nd, 2022 9:02 pm
Lucira Health Announces National Launch of Lucira Connect Test-to-Treat Service - Nov 17th, 2022 12:03 pm
Lucira Health Announces Third Quarter 2022 Results and Provides Business Updates - Nov 14th, 2022 9:02 pm
Lucira Health cuts quarter of workforce as it awaits FDA decision on combo Covid-flu test - Nov 8th, 2022 11:02 pm
Lucira Health to Announce Third Quarter 2022 Financial Results - Nov 1st, 2022 11:00 am
Lucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea Assays - Sep 29th, 2022 11:00 am
Lucira Health to Participate in LifeSci Partners HealthTech Symposium - Sep 7th, 2022 11:00 am
Lucira CEO: COVID-19 ‘catalyzed the growth of the company’ - Aug 31st, 2022 3:02 pm
Lucira Health to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase - Aug 23rd, 2022 11:00 am
Lucira Health, Inc. (LHDX) Q2 2022 Earnings Call Transcript - Aug 16th, 2022 3:00 am
Lucira Health Announces Second Quarter 2022 Results and Provides Business Updates - Aug 15th, 2022 8:01 pm
A Lucira Health, Inc. (NASDAQ:LHDX) insider increased their holdings by 11% last year - Aug 13th, 2022 2:16 pm